SDZ 224-015

Modify Date: 2024-01-10 10:39:35

SDZ 224-015 Structure
SDZ 224-015 structure
Common Name SDZ 224-015
CAS Number 161511-45-1 Molecular Weight 652.52
Density N/A Boiling Point N/A
Molecular Formula C30H35Cl2N3O9 Melting Point N/A
MSDS N/A Flash Point N/A

 Use of SDZ 224-015


SDZ 224-015 is an orally active inhibitor of the interleukin-1 beta (IL-1β) converting enzyme and caspase-1. SDZ 224-015 possesses anti-COVID-19 activity, targeting Mpro (IC50 of 30 nM)[1][2].

 Names

Name SDZ 224-015

 SDZ 224-015 Biological Activity

Description SDZ 224-015 is an orally active inhibitor of the interleukin-1 beta (IL-1β) converting enzyme and caspase-1. SDZ 224-015 possesses anti-COVID-19 activity, targeting Mpro (IC50 of 30 nM)[1][2].
Related Catalog
In Vivo SDZ 224-015 (0.3-300 μg/kg) potently reduces carrageenin-induced paw oedema[2]. SDZ 224-015 (0.2-5 mg/kg, p.o.) displays analgesic activity in the Randall-Selitto yeast-inflamed paw pressure test, significant at a dose of 1 mg/kg[2].
References

[1]. Martin A Redhead, et al. Bispecific repurposed medicines targeting the viral and immunological arms of COVID-19. Sci Rep. 2021 Jun 24;11(1):13208.

[2]. P R Elford, et al. Reduction of inflammation and pyrexia in the rat by oral administration of SDZ 224-015, an inhibitor of the interleukin-1 beta converting enzyme. Br J Pharmacol. 1995 Jun;115(4):601-6.

 Chemical & Physical Properties

Molecular Formula C30H35Cl2N3O9
Molecular Weight 652.52
Top Suppliers:I want be here

Get all suppliers and price by the below link:

SDZ 224-015 suppliers

SDZ 224-015 price